![](https://edgeaisummit.com/sites/default/files/styles/panopoly_image_square/public/speakers/michael_higgins.jpg?itok=rvqC0VxV&c=f9729898eff525303cdec6b70f929371)
Michael Higgins
Managing Director, Biopharmaceuticals Equity Research
Ladenburg Thalmann & Co. Inc.
![](https://edgeaisummit.com/sites/default/files/styles/panopoly_image_square/public/speakers/richard_alm.jpg?itok=irjsRbjT&c=abdf9dfa4489e3f4a96702547a5944c1)
Dr Richard Alm
Director of Alliances
CARB-X / Consultant, WHO
Richard joined CARB-X as an Alliance Director following almost 20 years in large pharma Infection R&D teams followed by 4 years at a small antibacterial biotech company. He has supported the progression of small molecule compounds from discovery through to late-stage clinical development. He obtained his PhD in molecular microbiology from the University of Adelaide, and prior to joining industry he held two post-doctoral positions in the AMR area, one in Australia and one in Canada. Richard is also a consultant on the Global Action Plan on Antimicrobial Resistance for the World Health Organization (WHO).
![](https://edgeaisummit.com/sites/default/files/styles/panopoly_image_square/public/speakers/headshot_2.jpg?itok=CHxyhQY0&c=298b6a182ccd20df1eea6197d03f7cc6)
Rima Raouda
Tech Researcher & Content Director
Independent
![](https://edgeaisummit.com/sites/default/files/styles/panopoly_image_square/public/speakers/davis_sawyer.jpeg?itok=b1DjIn6e&c=6dba7b88948980fbbbcf03bfaa1af0ab)
Davis Sawyer
Co-Founder and CPO
Deeplite